UCLH provides first-class acute and specialist services in six hospitals in central London.
University College Hospital (incorporating the Elizabeth Garrett Anderson Wing, University College Hospital Macmillan Cancer Centre and University College Hospital at Westmoreland Street)
Royal London Hospital for Integrated Medicine
Royal National ENT and Eastman Dental Hospitals
National Hospital for Neurology and Neurosurgery at Queen Square and Cleveland Street
Institute of Sport and Exercise Health
Hospital for Tropical Diseases
Our mission is to deliver top-quality patient care, excellent education and world-class research.
In partnership with University College London (UCL) we are one of the country’s five comprehensive biomedical research centres. We are a member of UCL Partners which brings together some of the UK's world-renowned medical research centres and hospitals.
University College Hospital (incorporating the Elizabeth Garrett Anderson Wing, University College Hospital Macmillan Cancer Centre and University College Hospital at Westmoreland Street)
Royal London Hospital for Integrated Medicine
Royal National ENT and Eastman Dental Hospitals
National Hospital for Neurology and Neurosurgery at Queen Square and Cleveland Street
Institute of Sport and Exercise Health
Hospital for Tropical Diseases
Our mission is to deliver top-quality patient care, excellent education and world-class research.
In partnership with University College London (UCL) we are one of the country’s five comprehensive biomedical research centres. We are a member of UCL Partners which brings together some of the UK's world-renowned medical research centres and hospitals.
Location: United Kingdom, England, London
Employees: 10001+
Phone: +44 20 3456 7890
Mentions in press and media 30
| Date | Title | Description |
| 17.08.2026 | Opt-out testing for hepatitis C seen as key to fighting disease | Getting your Trinity Audio player ready... By Jessie Hellmann, CQ-Roll Call LONDON — At King’s College Hospital in the south of London, anyone who has blood drawn in the emergency department is automatically tested for hepatitis B and C. Po... |
| 07.05.2026 | Cambridge University Hospitals announces Nicola Ayton as Chief Executive | Cambridge University Hospitals NHS Foundation Trust (CUH) has appointed Nicola Ayton as Chief Executive, following a competitive recruitment process. She had been serving as interim Chief Executive since 1 January 2026. Ayton joined CUH in ... |
| 17.02.2026 | Klaris raises $1M to address regulatory challenges in medtech | London-based Klaris, an AI-driven medtech startup focused on automating regulatory compliance for medical device companies, has closed a $1 million pre-seed funding round. The round was led by Meridian Health Ventures, a specialist fund bac... |
| 07.01.2026 | Bial Launches KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom | Bial, an innovation-driven biopharmaceutical company, today announced the launch of KYNMOBI® (apomorphine hydrochloride) in the United Kingdom, the first sublingual film indicated for the intermittent treatment of OFF episodes in adult pati... |
| 18.12.2025 | HCA Healthcare UK Goes On “The Cloud” with MEDITECH Expanse EHR, Powering Patient-Centred Care | Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and improving workflow efficiencies. This press r... |
| 03.12.2025 | Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocar... | For United Kingdom (UK) Trade and Medical Media Only Taiho Oncology Europe GmbH announced today the UK launch of Lytgobi® (futibatinib), an irreversibly binding fibroblast growth factor receptor (FGFR) inhibitor.1,3 This development follows... |
| 31.07.2025 | Musk's Neuralink to test brain chips in clinical study in Great Britain | Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The com... |
| 16.07.2025 | Update on anselamimab in AL amyloidosis | Update on anselamimab in AL amyloidosis Wed, Jul 16, 2025 08:00 CET Report this content 16 July 2025 Update on CARES Phase III clinical programme of anselamimab in light chain amyloidosis Results did not achieve statistical significance for... |
| 13.06.2025 | The Regulatory Quagmire: A Call for Reform in the UK Financial Sector | The UK financial landscape is at a crossroads. Regulators, tasked with fostering growth, are instead mired in a culture of risk aversion. A recent House of Lords report paints a stark picture of stagnation. The Financial Conduct Authority (... |
| 13.06.2025 | Bank of England loses hundreds of laptops amid rising cyber threats | The Bank of England has come under fire after losing hundreds of tech devices worth nearly £300,000. Figures seen by City AM reveal the Bank of England lost or had stolen over 300 laptops, tablets and phones between May 2022 and March 2025.... |
Show more